Melanoma
This magazine is directed toward patients with Melanoma, their families, care givers, physicians and researchers. The content is gathered, validated, categorized, and supplied using a novel big data cyberinfrastructure technology that continually learns about Melanoma.
You may filter the results to view only the latest news, media (podcasts and videos) or scientific literature using these buttons.
-
-
-
A Decade of Transformation in Melanoma Treatments
Publication date: May 24, 2022 The trials that led to the approval showed an overall ... -
Promising peptide slows the spread and growth of melanoma in mice
Publication date: May 24, 2022 The treatment also increased group survival by more than 25 ... -
Pierre Fabre and EORTC open a large Phase III clinical study in the adjuvant setting of stage IIB-C melanoma
Publication date: May 24, 2022 “The screening of patients for COLUMBUS-AD focuses on patients with ... -
Skin Microenvironment Could Yield New Melanoma Treatment Options, Study Finds
Publication date: May 23, 2022 Cutaneous melanoma is the result of a proliferation of melanocytes, ... -
Anaphylactic reaction to carboplatin diagnosed by skin testing-a reliable tool in platinum-based immediate-type hypersensitivity reactions.
Publication date: May 20, 2022 Immediate-type hypersensitivity reactions (IHRs) to carboplatin (CA) are most commonly ... -
Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: a phase I study.
Publication date: May 20, 2022 Anti-programmed cell death receptor-1 (PD-1) monotherapy is the standard treatment ... -
Fatal melanoma with a novel MYO5A-BRAF fusion and small associated conventional nevus: A Case Report and Review of Literature.
Publication date: May 21, 2022 Kinase fusions play an important role in the pathogenesis of ... -
Experiences of resuming life after immunotherapy and associated survivorship care needs: a qualitative study among patients with metastatic melanoma.
Publication date: May 21, 2022 Immune checkpoint inhibitors (ICIs) have improved the overall survival of ... -
Fast raster-scan optoacoustic mesoscopy enables assessment of human melanoma microvasculature in vivo.
Publication date: May 19, 2022 Melanoma is associated with angiogenesis and vascular changes that may ... -
Exploring supportive care and information needs through a proposed eHealth application among melanoma patients undergoing systemic therapy: a qualitative study.
Publication date: May 19, 2022 During and after systemic therapy, patients with high risk and ... -
Deep Visual Proteomics defines single-cell identity and heterogeneity.
Publication date: May 19, 2022 Despite the availabilty of imaging-based and mass-spectrometry-based methods for spatial ... -
Restorative biodegradable two-layered hybrid microneedles for melanoma photothermal/chemo co-therapy and wound healing.
Publication date: May 19, 2022 Tumor killing and wound healing are two complementary and influential ... -
Framework Nucleic Acid Immune Adjuvant for Transdermal Delivery Based Chemo-immunotherapy for Malignant Melanoma Treatment.
Publication date: May 20, 2022 Despite the tremendous progresses of cancer immunotherapy, its current clinical ... -
Lithium Enhances Autophagy and Cell Death in Skin Melanoma: An Ultrastructural and Immunohistochemical Study.
Publication date: May 20, 2022 Lithium is an inhibitor of glycogen synthase kinase 3 beta, ... -
Diagnostic impact of F-FDG PET/CT imaging on the detection of immune-related adverse events in patients treated with immunotherapy.
Publication date: May 20, 2022 Immunotherapy is an effective treatment method for cancer cells with ... -
5-Aza-dC suppresses melanoma progression by inhibiting GAS5 hypermethylation.
Publication date: Jul 01, 2022 The in-depth study of melanoma pathogenesis has revealed that epigenetic ... -
-
A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers
Publication date: May 20, 2022 This Phase 1b/2a study will assess the efficacy, safety, and ... -
Axitinib and Nivolumab for the Treatment of Mucosal Melanoma
Publication date: May 20, 2022 The researchers are doing this study to find out whether ...